Crinetics Pharmaceuticals(CRNX) - 2025 Q4 - Annual Report
Crinetics Pharmaceuticals(US:CRNX)2026-02-26 21:25UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Crinetics Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) ____________________________________________________________ Form 10-K ____________________________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ...